Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Shelley Crary

Concepts (160)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Vascular Malformations
7
2023
98
3.400
Why?
Blood Coagulation Disorders
4
2022
33
2.810
Why?
Splenectomy
10
2018
34
1.770
Why?
Spherocytosis, Hereditary
6
2015
14
1.550
Why?
Sclerotherapy
3
2022
45
1.520
Why?
Kasabach-Merritt Syndrome
2
2023
4
1.080
Why?
Hemangioendothelioma
2
2023
7
1.080
Why?
Hemophilia A
2
2024
25
1.030
Why?
Sarcoma, Kaposi
2
2023
72
0.980
Why?
Child
27
2024
6847
0.880
Why?
Child, Preschool
20
2024
3871
0.830
Why?
Anticoagulants
2
2018
250
0.770
Why?
Thrombelastography
1
2020
24
0.740
Why?
Hemostasis
1
2020
55
0.720
Why?
Anemia, Sickle Cell
5
2021
96
0.720
Why?
Sirolimus
2
2023
62
0.710
Why?
Bleomycin
2
2022
35
0.660
Why?
Autoimmune Lymphoproliferative Syndrome
1
2018
2
0.640
Why?
Adolescent
20
2024
6356
0.620
Why?
Antibiotics, Antineoplastic
1
2018
78
0.580
Why?
Purpura, Thrombocytopenic, Idiopathic
3
2024
23
0.560
Why?
Postoperative Complications
3
2014
984
0.530
Why?
Young Adult
11
2024
3958
0.530
Why?
Hematinics
2
2013
12
0.490
Why?
Reticulocyte Count
2
2015
4
0.490
Why?
Anemia, Iron-Deficiency
2
2013
19
0.490
Why?
Hemorrhage
4
2024
197
0.470
Why?
Heart Transplantation
1
2018
312
0.470
Why?
Humans
36
2024
49974
0.470
Why?
Infant
12
2024
3567
0.430
Why?
Adult
12
2024
13236
0.420
Why?
Hematologic Diseases
2
2009
22
0.420
Why?
Female
21
2024
26472
0.410
Why?
Male
21
2024
25241
0.390
Why?
Ferric Compounds
1
2010
11
0.380
Why?
Hypertension, Pulmonary
1
2011
114
0.350
Why?
Vascular Diseases
2
2009
75
0.340
Why?
Blood Flow Velocity
2
2020
101
0.340
Why?
Retrospective Studies
10
2024
6108
0.340
Why?
Enoxaparin
1
2008
27
0.320
Why?
Thromboembolism
1
2006
54
0.270
Why?
Venous Thrombosis
1
2006
90
0.260
Why?
Osteomyelitis
1
2006
126
0.250
Why?
Cardiovascular Diseases
1
2010
440
0.250
Why?
Prospective Studies
6
2023
2364
0.240
Why?
Hemoglobins
4
2015
107
0.240
Why?
Factor VIII
1
2024
23
0.240
Why?
von Willebrand Diseases
1
2024
22
0.230
Why?
Vascular Neoplasms
1
2023
17
0.230
Why?
Administration, Oral
2
2018
426
0.230
Why?
Anemia, Hemolytic, Congenital
2
2014
4
0.230
Why?
Autoantibodies
1
2024
116
0.220
Why?
Factor IX
1
2023
1
0.220
Why?
Hemophilia B
1
2023
4
0.220
Why?
Critical Illness
2
2020
288
0.220
Why?
Hemangioma
1
2023
83
0.210
Why?
Genetic Therapy
1
2023
114
0.200
Why?
Databases, Factual
2
2024
658
0.200
Why?
Acute Pain
1
2021
8
0.200
Why?
Pupil
1
2021
30
0.200
Why?
Anxiety
1
2024
274
0.200
Why?
Treatment Outcome
5
2022
5141
0.200
Why?
Mental Health
1
2024
219
0.200
Why?
Infusions, Intravenous
3
2013
206
0.200
Why?
Middle Aged
7
2024
12069
0.190
Why?
Arterial Occlusive Diseases
1
2021
79
0.190
Why?
Blood Coagulation Tests
1
2020
19
0.190
Why?
Blood Coagulation
1
2020
56
0.180
Why?
Multiple Organ Failure
1
2020
47
0.180
Why?
Antibodies, Monoclonal, Humanized
1
2021
225
0.170
Why?
Klippel-Trenaunay-Weber Syndrome
1
2019
4
0.170
Why?
Receptors, Fc
1
2019
10
0.170
Why?
Thrombopoietin
1
2019
11
0.170
Why?
Pain
2
2021
379
0.170
Why?
Vitiligo
1
2019
8
0.170
Why?
Leukoencephalopathies
1
2019
14
0.160
Why?
Autoimmune Diseases of the Nervous System
1
2019
9
0.160
Why?
Depression
1
2024
568
0.160
Why?
Nervous System Malformations
1
2019
17
0.160
Why?
Alopecia
1
2019
39
0.160
Why?
Recombinant Fusion Proteins
1
2019
181
0.160
Why?
Fibrin Fibrinogen Degradation Products
1
2018
10
0.160
Why?
Fibrinogen
1
2018
31
0.160
Why?
Skin Neoplasms
1
2023
488
0.160
Why?
Bilirubin
3
2015
40
0.160
Why?
Thrombocytopenia
1
2019
85
0.150
Why?
Autoimmune Diseases
1
2019
101
0.150
Why?
Follow-Up Studies
2
2021
2182
0.140
Why?
Aged
5
2024
9310
0.130
Why?
Cross-Sectional Studies
2
2011
1557
0.130
Why?
Hydroxyurea
1
2015
30
0.130
Why?
Prevalence
2
2024
944
0.120
Why?
Ankyrins
1
2014
9
0.120
Why?
Acute Chest Syndrome
1
2014
8
0.120
Why?
Diagnosis, Differential
1
2018
1037
0.120
Why?
Risk Factors
4
2024
3613
0.120
Why?
Platelet Count
2
2019
72
0.120
Why?
Respiratory Tract Infections
1
2014
75
0.120
Why?
Iron-Dextran Complex
1
2013
3
0.110
Why?
Quality of Life
1
2019
836
0.110
Why?
Hematoma
1
2013
64
0.110
Why?
Protein Precursors
1
2011
43
0.100
Why?
Remission, Spontaneous
1
2011
25
0.100
Why?
Anemia, Hemolytic
1
2011
11
0.100
Why?
Tricuspid Valve
1
2011
21
0.100
Why?
Natriuretic Peptide, Brain
1
2011
29
0.100
Why?
Texas
1
2011
137
0.100
Why?
Early Diagnosis
1
2011
88
0.100
Why?
Glucaric Acid
1
2010
1
0.100
Why?
Aged, 80 and over
2
2024
3129
0.090
Why?
Infant, Newborn
3
2024
2772
0.090
Why?
Blood Cell Count
1
2010
37
0.090
Why?
Cholesterol, LDL
1
2010
34
0.090
Why?
Lipids
1
2010
147
0.090
Why?
C-Reactive Protein
1
2010
142
0.090
Why?
Ultrasonography
1
2011
436
0.090
Why?
Neoplasms
1
2019
1235
0.080
Why?
Medical Audit
1
2008
21
0.080
Why?
Cholesterol
1
2007
146
0.070
Why?
Acute Disease
1
2006
366
0.060
Why?
Thrombosis
1
2007
248
0.060
Why?
Terminology as Topic
1
2024
62
0.060
Why?
Vincristine
1
2023
89
0.060
Why?
Disease Management
1
2024
174
0.050
Why?
Genetic Vectors
1
2023
125
0.050
Why?
Ambulatory Care Facilities
1
2023
125
0.050
Why?
Alleles
1
2023
250
0.050
Why?
Genetic Testing
1
2023
119
0.050
Why?
Sclerosing Solutions
1
2022
14
0.050
Why?
Registries
2
2015
522
0.050
Why?
Educational Status
1
2023
222
0.050
Why?
P-Selectin
1
2021
32
0.050
Why?
Analgesics
1
2021
100
0.050
Why?
Pain Measurement
1
2021
240
0.050
Why?
Intensive Care Units, Pediatric
1
2020
169
0.040
Why?
United States
2
2024
4860
0.040
Why?
Clinical Trials as Topic
1
2021
461
0.040
Why?
Disease Susceptibility
1
2019
89
0.040
Why?
Time Factors
2
2019
2903
0.040
Why?
Incidence
1
2021
1003
0.040
Why?
Disease-Free Survival
1
2019
454
0.040
Why?
Length of Stay
1
2020
619
0.040
Why?
Survival Rate
1
2019
894
0.030
Why?
Immunosuppressive Agents
1
2018
221
0.030
Why?
Therapeutic Equivalency
1
2015
7
0.030
Why?
Solutions
1
2015
25
0.030
Why?
Capsules
1
2015
30
0.030
Why?
Antisickling Agents
1
2015
13
0.030
Why?
Decision Making
1
2018
265
0.030
Why?
Reticulocytes
1
2014
9
0.030
Why?
Physicians
1
2018
233
0.030
Why?
Risk Assessment
1
2019
1259
0.030
Why?
Forehead
1
2013
8
0.030
Why?
Laparoscopy
1
2015
170
0.030
Why?
Molecular Weight
1
2013
84
0.030
Why?
Syndrome
1
2011
237
0.020
Why?
Hemolysis
1
2009
27
0.020
Why?
Thrombocytosis
1
2007
4
0.020
Why?
Polycythemia
1
2007
9
0.020
Why?
Wounds and Injuries
1
2009
276
0.020
Why?
Crary's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description